• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种以舌下生物粘附膜形式存在的速尿无定形固体分散体的开发与表征,以提高生物利用度。

Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability.

作者信息

De Caro Viviana, Ajovalasit Alessia, Sutera Flavia Maria, Murgia Denise, Sabatino Maria Antonietta, Dispenza Clelia

机构信息

Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Palermo, PA 90123, Italy.

Dipartimento dell'Innovazione Industriale e Digitale, Ingegneria Chimica, Gestionale, Informatica, Meccanica, Università degli Studi di Palermo, Palermo, PA 90128, Italy.

出版信息

Pharmaceutics. 2017 Jun 24;9(3):22. doi: 10.3390/pharmaceutics9030022.

DOI:10.3390/pharmaceutics9030022
PMID:28672810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5620563/
Abstract

Administered by an oral route, Furosemide (FUR), a diuretic used in several edematous states and hypertension, presents bioavailability problems, reported as a consequence of an erratic gastrointestinal absorption due to various existing polymorphic forms and low and pH-dependent solubility. A mucoadhesive sublingual fast-dissolving FUR based film has been developed and evaluated in order to optimize the bioavailability of FUR by increasing solubility and guaranteeing a good dissolution reproducibility. The Differential Scanning Calorimetry (DSC) analyses confirmed that the film prepared using the solvent casting method entrapped FUR in the amorphous state. As a solid dispersion, FUR increases its solubility up to 28.36 mg/mL. Drug content, thickness, and weight uniformity of film were also evaluated. The measured Young's Modulus, yield strength, and relative elongation of break percentage (EB%) allowed for the classification of the drug-loaded film as an elastomer. Mucoadhesive strength tests showed that the force to detach film from mucosa grew exponentially with increasing contact time up to 7667 N/m². FUR was quickly discharged from the film following a trend well fitted with the Weibull kinetic model. When applied on sublingual mucosa, the new formulation produced a massive drug flux in the systemic compartment. Overall, the proposed sublingual film enhances drug solubility and absorption, allowing for the prediction of a rapid onset of action and reproducible bioavailability in its clinical application.

摘要

速尿(FUR)是一种用于多种水肿状态和高血压的利尿剂,经口服给药时存在生物利用度问题,这是由于存在多种多晶型形式以及低溶解度和pH依赖性溶解度导致胃肠道吸收不稳定所致。为了通过提高溶解度并确保良好的溶出重现性来优化FUR的生物利用度,已开发并评估了一种基于速尿的粘膜粘附舌下速溶膜。差示扫描量热法(DSC)分析证实,采用溶剂浇铸法制备的膜将FUR包裹在无定形状态。作为一种固体分散体,FUR的溶解度提高到了28.36 mg/mL。还评估了膜的药物含量、厚度和重量均匀性。测得的杨氏模量、屈服强度和断裂伸长率百分比(EB%)使得载药膜可归类为弹性体。粘膜粘附强度测试表明,随着接触时间增加,膜从粘膜上分离所需的力呈指数增长,最高可达7667 N/m²。FUR从膜中快速释放,其趋势与威布尔动力学模型拟合良好。当应用于舌下粘膜时,新制剂在全身隔室中产生大量药物通量。总体而言,所提出的舌下膜提高了药物溶解度和吸收,在其临床应用中可预测起效迅速且生物利用度具有重现性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/0aa3394dcf43/pharmaceutics-09-00022-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/92cbc7183654/pharmaceutics-09-00022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/181fbd856494/pharmaceutics-09-00022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/b5808df6d88b/pharmaceutics-09-00022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/4d0757efb76d/pharmaceutics-09-00022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/7d718dd98520/pharmaceutics-09-00022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/9a8cad7467fa/pharmaceutics-09-00022-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/0aa3394dcf43/pharmaceutics-09-00022-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/92cbc7183654/pharmaceutics-09-00022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/181fbd856494/pharmaceutics-09-00022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/b5808df6d88b/pharmaceutics-09-00022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/4d0757efb76d/pharmaceutics-09-00022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/7d718dd98520/pharmaceutics-09-00022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/9a8cad7467fa/pharmaceutics-09-00022-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf3/5620563/0aa3394dcf43/pharmaceutics-09-00022-g007.jpg

相似文献

1
Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability.一种以舌下生物粘附膜形式存在的速尿无定形固体分散体的开发与表征,以提高生物利用度。
Pharmaceutics. 2017 Jun 24;9(3):22. doi: 10.3390/pharmaceutics9030022.
2
Formulation and Characterization of Fast-Dissolving Sublingual Film of Iloperidone Using Box-Behnken Design for Enhancement of Oral Bioavailability.采用 Box-Behnken 设计制备伊洛哌酮速溶舌下膜以提高口服生物利用度。
AAPS PharmSciTech. 2018 Apr;19(3):1392-1400. doi: 10.1208/s12249-018-0954-y. Epub 2018 Feb 2.
3
Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.呋塞米固体分散体的制备及增溶和生物利用度的改善。
AAPS PharmSciTech. 2022 Jan 31;23(1):65. doi: 10.1208/s12249-022-02208-w.
4
Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.用于提高酒石酸美托洛尔生物利用度和延长其作用时间的舌下速溶脂质体膜剂。
Drug Des Devel Ther. 2016 Aug 2;10:2421-33. doi: 10.2147/DDDT.S113775. eCollection 2016.
5
Development and Evaluation of Solid Dispersion-Based Sublingual Films of Nisoldipine.尼索地平固体分散体舌下膜剂的研制与评价
Pharmaceuticals (Basel). 2023 Nov 9;16(11):1589. doi: 10.3390/ph16111589.
6
In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids.含奥氮平与特定羧酸共无定形分散体的优化速溶口腔膜的体外/体内评价
Drug Deliv. 2016 Oct;23(8):3088-3100. doi: 10.3109/10717544.2016.1153746. Epub 2016 Mar 10.
7
Preparation and evaluation of sublingual film of ketorolac tromethamine.酮咯酸氨丁三醇舌下膜的制备与评价。
Drug Dev Ind Pharm. 2022 Sep;48(9):438-445. doi: 10.1080/03639045.2022.2123925. Epub 2022 Sep 27.
8
Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.具有改善溶出度和生物利用度的鸢尾黄素固体分散体的制备、表征及体内外评价
Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):413-22. doi: 10.1007/s13318-015-0265-6. Epub 2015 Feb 11.
9
Fabrication and characterization of orodispersible films loaded with solid dispersion to enhance Rosuvastatin calcium bioavailability.载有固体分散体的口腔崩解膜的制备与表征以提高瑞舒伐他汀钙的生物利用度。
Saudi Pharm J. 2023 Jan;31(1):135-146. doi: 10.1016/j.jsps.2022.11.012. Epub 2022 Nov 23.
10
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.

引用本文的文献

1
In Vitro and Biological Evaluation of Oral Fast-Disintegrating Films Containing Ranitidine HCl and Syloid 244FP-Based Ternary Solid Dispersion of Flurbiprofen.含盐酸雷尼替丁和基于Syloid 244FP的氟比洛芬三元固体分散体的口腔速崩膜的体外及生物学评价
Pharmaceutics. 2024 Jan 24;16(2):164. doi: 10.3390/pharmaceutics16020164.
2
Buccal Thin Films as Potent Permeation Enhancers for Cytisine Transbuccal Delivery.作为野靛碱经颊给药有效渗透促进剂的口腔薄膜
Membranes (Basel). 2022 Nov 21;12(11):1169. doi: 10.3390/membranes12111169.
3
Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review.

本文引用的文献

1
Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride.用于盐酸普萘洛尔口腔给药的黏膜黏附性壳聚糖/明胶膜
Carbohydr Polym. 2012 Jan 4;87(1):581-588. doi: 10.1016/j.carbpol.2011.08.024. Epub 2011 Aug 17.
2
Development and Evaluation of Buccal Films Based on Chitosan for the Potential Treatment of Oral Candidiasis.基于壳聚糖的口腔膜用于口腔念珠菌病潜在治疗的开发与评价
AAPS PharmSciTech. 2017 May;18(4):936-946. doi: 10.1208/s12249-017-0720-6. Epub 2017 Jan 20.
3
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs.
固体分散体技术作为一种制剂策略用于制备缓控释剂型:全面综述。
Daru. 2022 Jun;30(1):165-189. doi: 10.1007/s40199-022-00440-0. Epub 2022 Apr 18.
4
Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy beagle dogs.在健康比格犬中单静脉注射、口服片剂和新开发的口服分散片给药后,呋塞米的药代动力学和利尿作用。
BMC Vet Res. 2021 Sep 6;17(1):295. doi: 10.1186/s12917-021-02998-4.
5
Chlorhexidine Mucoadhesive Buccal Tablets: The Impact of Formulation Design on Drug Delivery and Release Kinetics Using Conventional and Novel Dissolution Methods.洗必泰粘膜粘附口腔片:使用传统和新型溶出方法的制剂设计对药物递送和释放动力学的影响。
Pharmaceuticals (Basel). 2021 May 23;14(6):493. doi: 10.3390/ph14060493.
6
Amorphous Ropinirole-Loaded Mucoadhesive Buccal Film: A Potential Patient-Friendly Tool to Improve Drug Pharmacokinetic Profile and Effectiveness.载有无定形罗匹尼罗的黏膜黏附性口腔膜:一种改善药物药代动力学特征和有效性的潜在的患者友好型工具。
J Pers Med. 2020 Nov 25;10(4):242. doi: 10.3390/jpm10040242.
7
Development of a Multifunctional Bioerodible Nanocomposite Containing Metronidazole and Curcumin to Apply on L-PRF Clot to Promote Tissue Regeneration in Dentistry.一种含甲硝唑和姜黄素的多功能可生物降解纳米复合材料的研制,用于应用于富血小板纤维蛋白凝块以促进牙科组织再生。
Biomedicines. 2020 Oct 16;8(10):425. doi: 10.3390/biomedicines8100425.
8
Bioadhesive Matrix Tablets Loaded with Lipophilic Nanoparticles as Vehicles for Drugs for Periodontitis Treatment: Development and Characterization.载有亲脂性纳米颗粒的生物黏附基质片作为牙周炎治疗药物载体的研发与表征
Polymers (Basel). 2019 Nov 2;11(11):1801. doi: 10.3390/polym11111801.
9
Engineering of Nanofibrous Amorphous and Crystalline Solid Dispersions for Oral Drug Delivery.用于口服给药的纳米纤维无定形和结晶性固体分散体的工程设计
Pharmaceutics. 2018 Dec 24;11(1):7. doi: 10.3390/pharmaceutics11010007.
多晶型对难溶性药物生物利用度和稳定性的影响。
Molecules. 2015 Oct 15;20(10):18759-76. doi: 10.3390/molecules201018759.
4
Loop Diuretics in Clinical Practice.临床实践中的袢利尿剂
Electrolyte Blood Press. 2015 Jun;13(1):17-21. doi: 10.5049/EBP.2015.13.1.17. Epub 2015 Jun 30.
5
Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.通过共研磨法制备用于改善呋塞米溶出度的固体分散体及其表征
Adv Pharm Bull. 2014 Dec;4(4):391-9. doi: 10.5681/apb.2014.058. Epub 2014 Aug 10.
6
Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system.芦荟素在颊黏膜的递送:体外研究及新型局部给药系统的设计
Drug Dev Ind Pharm. 2015;41(9):1541-7. doi: 10.3109/03639045.2014.971030. Epub 2015 Jul 14.
7
Improving furosemide polymorphs properties through supramolecular complexes of β-cyclodextrin.通过β-环糊精超分子复合物改善速尿多晶型物的性质。
J Pharm Biomed Anal. 2014 Jul;95:139-45. doi: 10.1016/j.jpba.2014.02.017. Epub 2014 Mar 3.
8
Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.通过杯芯型口腔崩解片提高盐酸丁螺环酮的生物利用度:制剂及体外/体内评价
Int J Pharm. 2014 Mar 10;463(1):68-80. doi: 10.1016/j.ijpharm.2014.01.003. Epub 2014 Jan 8.
9
Mechanical strength test for orodispersible and buccal films.口腔崩解片和口腔贴片的机械强度测试。
Int J Pharm. 2014 Jan 30;461(1-2):22-9. doi: 10.1016/j.ijpharm.2013.11.033. Epub 2013 Nov 26.
10
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.